SGHT Earnings Date: Nov 4, 2026 (Estimated) — Sight Sciences, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is SGHT's next earnings date?
Sight Sciences, Inc. (SGHT) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.12 on revenue of $23.5M.
How did SGHT do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Sight Sciences, Inc. posted EPS of -$0.08 versus the -$0.18 estimate, a beat of 52.9%. Revenue was $23.4M against a $21.7M estimate. The stock's 1-day post-earnings move was +27.7%.
How much does SGHT stock move after earnings?
SGHT beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 17.6% (up or down) in the day after earnings.
About Sight Sciences, Inc.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.18 | -0.08 | +52.94% | $23.4M | ✅ Beat | +27.75% | +49.19% | +50.99% |
| 2026-05-06 | Q1 2026 | -0.20 | -0.24 | -20.00% | $19.7M | ❌ Miss | +23.02% | +13.95% | +3.49% |
| 2026-03-04 | Q4 2025 | -0.15 | -0.08 | +46.67% | $20.4M | ✅ Beat | -26.80% | -31.61% | -34.94% |
| 2025-11-06 | Q3 2025 | -0.26 | -0.16 | +38.46% | $19.9M | ✅ Beat | +16.40% | +41.00% | +70.60% |
| 2025-08-07 | Q2 2025 | -0.27 | -0.23 | +14.81% | $19.6M | ✅ Beat | +19.44% | +19.72% | +3.94% |
| 2025-03-05 | Q4 2024 | -0.18 | -0.23 | -27.78% | $19.1M | ❌ Miss | +2.89% | +11.16% | -7.85% |
| 2024-11-07 | Q3 2024 | -0.21 | -0.22 | -4.76% | $20.2M | ❌ Miss | -9.62% | -17.52% | -14.74% |
| 2024-08-01 | Q2 2024 | -0.30 | -0.25 | +16.67% | $21.4M | ✅ Beat | -14.96% | -21.43% | -8.76% |
Showing last 8 quarters.